











T cell reactivity against citrullinated proteins does not differ between 
healthy persons and patients with inflammatory arthritis 
Objectives: 
Rheumatoid Arthritis (RA) and Spondyloarthropathy (SpA) are two inflammatory auto-immune 
diseases. They can be distinguished by clinical presentation and the presence of antibodies 
to citrullinated proteins (ACPA), which is specific for RA. Production of these serological 
markers indicates a predominant role for B-cells in the pathology of RA. However, little is 
known about the effect of citrullinated proteins on T-cell reactivity. 
Methods: 
PBMC were isolated from healthy volunteers (n=6), RA-patients (CCP+ (n=5) and CCP- 
(n=5)) and SpA-patients (n=6). The IFN-production was evaluated by ELISpot analysis. 
PBMC (500000/100µL) were stimulated with in vitro citrullinated (cit) and non-citrullinated 
(non-cit) human cell extract, each at a concentration of 200µg/ml and 20U/ml IL2 was added. 
In order to identify the cells that were crucial in the citrulline-induced T cell reactivity, 
depletion experiments for CD4, CD8 and HLA-DR were performed according to the 
manufacturer’s protocol (Miltenyi Biotec). In parallel, 10^6 PBMC were cultured for 7 days in 
the presence of cit (80µg/ml) or non-cit (80µg/ml). Supernatants were collected and the 
secretion of cytokines was evaluated by multiple ELISAs (detecting IL-2, IL-4, IL-5, IL-6, IL-
10, IL-12, IL-13, IL-17a, IFN, TNF, G-CSF and TGF).  
Results: 
In the cultures of PBMCs of healthy persons, the RA and the SpA patients, the number of 
spot forming counts (SFC) when stimulated with cit was higher than when stimulated with non 
cit (significant difference= SFC (cit)- SFC (non cit) > (SD (cit)+ SD (non cit)). A significant 
difference was seen in 5 of the 6 healthy volunteers and in all the SpA patients. Unexpectedly 
this phenomenon was less distinct in RA (2/5 CCP+ and 4/5 CCP-), while patients with 
inflammatory arthritis contain high amounts of citrullinated proteins in their joints.  
After depletion of HLA DR positive cells a major drop in reactivity was observed, which 
illustrates the crucial role of an antigen presenting cell in the citrulline-specific T cell reactivity. 
Depletion experiments for CD4 and CD8 positive cells showed that both cell types were 
involved. 
The cytokine profile, determined from the multiple ELISAs showed a great resemblance 
between healthy, RA and SpA patients. For IL2, IL10, IL17 and IL6 an overall greater 
response to cit compared to non cit was detected. On the contrary, for TGF, a greater 
response to non cit, compared to cit, was seen. 
Conclusion: 
These data show that citrulline-reactive IFN producing T-cells are present in the repertoire of 
RA patients, SpA patients and healthy people. This implicates that T cell stimulation with 
citrullinated proteins is a universal mechanism and that ACPA production in RA is not due to 
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